Drugs

Understanding Drug Classes

Many new cancer drugs are entering clinical practice and clinical trials. Many GIST patients are no longer responding to Gleevec or Sutent and thus are looking for clinical trials. Understanding strategies and grouping these new drugs into classes with other similar drugs may help patients understand some of their choices.

By |2019-09-23T14:33:52-04:00December 5th, 2012|GIST Education, Research|
Go to Top